Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Rudolf T. Hoogenveen"'
Autor:
Sylvia Notenboom, Rudolf T. Hoogenveen, Marco J. Zeilmaker, Annick D. Van den Brand, Ricardo Assunção, Marcel J. B. Mengelers
Publikováno v:
Toxins, Vol 15, Iss 9, p 569 (2023)
Toxicokinetic modelling provides a powerful tool in relating internal human exposure (i.e., assessed through urinary biomarker levels) to external exposure. Chemical specific toxicokinetic models are available; however, this specificity prevents thei
Externí odkaz:
https://doaj.org/article/4ac20747e9234f9f8da6f9c564710b1f
Autor:
Marije Oosterhoff, Eelco A. B. Over, Anoukh van Giessen, Rudolf T. Hoogenveen, Hans Bosma, Onno C. P. van Schayck, Manuela A. Joore
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background This study estimated the lifetime cost-effectiveness and equity impacts associated with two lifestyle interventions in the Dutch primary school setting (targeting 4–12 year olds). Methods The Healthy Primary School of the Future
Externí odkaz:
https://doaj.org/article/fe55c3f5f0374ce78215ab5e9ddeabd3
Autor:
Hans Bosma, Marije Oosterhoff, Manuela A. Joore, Onno C. P. van Schayck, Rudolf T. Hoogenveen, Anoukh van Giessen, Eelco A. B. Over
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-15 (2020)
BMC Public Health, 20(1):1887. BioMed Central Ltd
BMC Public Health
BMC Public Health, 20(1):1887. BioMed Central Ltd
BMC Public Health
Background This study estimated the lifetime cost-effectiveness and equity impacts associated with two lifestyle interventions in the Dutch primary school setting (targeting 4–12 year olds). Methods The Healthy Primary School of the Future (HPSF; a
Publikováno v:
PLoS ONE, Vol 4, Iss 5, p e5696 (2009)
BACKGROUND: Effective prevention of excessive alcohol use has the potential to reduce the public burden of disease considerably. We investigated the cost-effectiveness of Screening and Brief Intervention (SBI) for excessive alcohol use in primary car
Externí odkaz:
https://doaj.org/article/d52b0c4778914652bb8a0541b31b09e1
Autor:
Louis W. Niessen, M. C. de Bruijne, Rudolf T. Hoogenveen, J.M. Dekker, Caroline A. Baan, Giel Nijpels, A.A.W.A. van der Heijden, Talitha L Feenstra
Publikováno v:
Diabetic Medicine, 32(12), 1580-1587. Wiley-Blackwell
van der Heijden, A A W A, Feenstra, T L, Hoogenveen, R T, Niessen, L W, de Bruijne, M C, Dekker, J M, Baan, C A & Nijpels, G 2015, ' Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO model ', Diabetic Medicine, vol. 32, no. 12, pp. 1580-1587 . https://doi.org/10.1111/dme.12811
Diabetic Medicine: Journal of the British Diabetic Association, 32(12), 1580-1587. Wiley-Blackwell
Diabetic Medicine, 32(12), 1580-1587. Wiley
van der Heijden, A A W A, Feenstra, T L, Hoogenveen, R T, Niessen, L W, de Bruijne, M C, Dekker, J M, Baan, C A & Nijpels, G 2015, ' Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO model ', Diabetic Medicine, vol. 32, no. 12, pp. 1580-1587 . https://doi.org/10.1111/dme.12811
Diabetic Medicine: Journal of the British Diabetic Association, 32(12), 1580-1587. Wiley-Blackwell
Diabetic Medicine, 32(12), 1580-1587. Wiley
Aims To test a simulation model, the MICADO model, for estimating the long-term effects of interventions in people with and without diabetes.Methods The MICADO model includes micro-and macrovascular diseases in relation to their risk factors. The str
Autor:
Sarah H. Wild, Maureen P.M.H. Rutten-van Mölken, Colin R Simpson, Aziz Sheikh, Talitha L Feenstra, Susannah McLean, Rudolf T. Hoogenveen, Martine Hoogendoorn
Publikováno v:
McLean, S, Hoogendoorn, M, Hoogenveen, R T, Feenstra, T L, Wild, S, Simpson, C R, Rutten-van Molken, M & Sheikh, A 2016, ' Projecting the COPD population and costs in England and Scotland: 2011 to 2030 ', Scientific Reports, vol. 6, no. 31893 . https://doi.org/10.1038/srep31893
Scientific Reports, 6:31893. Nature Publishing Group
Scientific Reports, 6. Nature Publishing Group
Scientific Reports
Scientific Reports, 6:31893. Nature Publishing Group
Scientific Reports, 6. Nature Publishing Group
Scientific Reports
We aimed to estimate the prevalence, healthcare costs and number of deaths among people with chronic obstructive pulmonary disease (COPD) in England and Scotland 2011–2030. We adapted the Dutch COPD Model by using English and Scottish demographic,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c206e4a3ca99a963ea5747c3d25ece55
https://hdl.handle.net/20.500.11820/6c36d0ba-61a1-4098-a618-5a9a6e252183
https://hdl.handle.net/20.500.11820/6c36d0ba-61a1-4098-a618-5a9a6e252183
Autor:
Wilma J. Nusselder, Pieter van Baal, Rudolf T. Hoogenveen, Johan P. Mackenbach, Stefan K. Lhachimi, Henriette A. Smit, Hendriek C. Boshuizen
Publikováno v:
Demography 49 (2012) 4
Demography, 49(4), 1259-1283. Springer New York
Demography, 49(4), 1259-1283
Demography, 49(4), 1259-1283. Springer New York
Demography, 49(4), 1259-1283
In Health Impact Assessment (HIA), or priority-setting for health policy, effects of risk factors (exposures) on health need to be modeled, such as with a Markov model, in which exposure influences mortality and disease incidence rates. Because many
Autor:
Talitha L Feenstra, Maureen P.M.H. Rutten-van Mölken, Rudolf T. Hoogenveen, Maiwenn Al, Martine Hoogendoorn
Publikováno v:
Value in Health, 14(8), 1039-1047. Elsevier Ltd.
Value in Health, 14(8), 1039-1047. ELSEVIER SCIENCE INC
Value in Health, 14(8), 1039-1047. ELSEVIER SCIENCE INC
Objectives: To develop a stochastic population model of disease progression in chronic obstructive pulmonary disease (COPD) that includes the effects of COPD exacerbations on health-related quality of life, costs, disease progression, and mortality a
Autor:
Werner B. F. Brouwer, Rudolf T. Hoogenveen, Johan Polder, Talitha L Feenstra, Pieter van Baal
Publikováno v:
Health Economics, 20, 432-445. John Wiley & Sons Ltd.
Health Economics, 20(4), 432-445. Wiley
Health Economics, 20(4), 432-445. Wiley-Blackwell
Health Economics, 20(4), 432-445. Wiley
Health Economics, 20(4), 432-445. Wiley-Blackwell
The inclusion of medical costs in life years gained in economic evaluations of health care technologies has long been controversial. Arguments in favour of the inclusion of such costs are gaining support, which shifts the question from whether to how
Autor:
Jørgen Vestbo, Martine Hoogendoorn, Rudolf T. Hoogenveen, MP Rutten-van Mölken, Talitha L Feenstra
Publikováno v:
European Respiratory Journal, 37(3), 508-515. European Respiratory Society
European Respiratory Journal, 37(3), 508-515. EUROPEAN RESPIRATORY SOC JOURNALS LTD
European Respiratory Journal, 37(3), 508-515. EUROPEAN RESPIRATORY SOC JOURNALS LTD
The aim of our study was to estimate the case fatality of a severe exacerbation from long-term survival data presented in the literature.A literature search identified studies reporting >= 1.5 yr survival after a severe chronic obstructive pulmonary